Vincerx Pharma, Inc.
VINC
$0.049
-$0.006-10.91%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -61.49% | 12.92% | 84.35% | 15.16% | 56.04% |
| Total Depreciation and Amortization | 8.91% | 8.27% | 8.43% | 71.43% | 7.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -84.05% | 286.79% | -525.34% | 457.05% | 146.22% |
| Change in Net Operating Assets | 138.10% | -126.78% | 105.14% | -448.27% | -119.31% |
| Cash from Operations | 22.92% | 4.00% | 54.10% | 40.89% | 41.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.78% | -90.88% | -156.32% | -- | 128.21% |
| Cash from Investing | 24.78% | -90.88% | -156.32% | -- | 128.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,372.22% | -- | 18,181.72% | 66.67% | -52.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,372.22% | -- | 18,181.72% | 66.67% | -52.63% |
| Foreign Exchange rate Adjustments | 239.53% | 258.82% | -140.00% | 140.00% | -259.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 188.88% | -159.27% | 28.45% | -6.80% | 93.28% |